JXSS1900001 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-02-11 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2019-10-15 | view |
JXSS1900002 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-02-11 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2019-10-15 | view |
JXSL1900033 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-03-27 | | Bristol-Myers Squibb Pharma Eeig | In Review | 2019-03-26 | view |
JXSL1900034 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-03-27 | | Bristol-Myers Squibb Pharma Eeig | In Review | 2019-03-26 | view |
JXSS1900037 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-07-03 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2020-03-12 | view |
JXSS1900038 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-07-03 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2020-03-12 | view |
JYSB1900193 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2019-09-12 | view |
JYSB1900192 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2019-09-12 | view |
JXSL1900069 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-08-24 | | Bristol-Myers Squibb Company | In Review | 2019-08-23 | view |
JXSL1900085 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-09-16 | | Bristol-Myers Squibb Company | In Review | 2019-09-13 | view |
JXSL1900095 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-09-28 | | Bristol-Myers Squibb Company | In Review | 2019-09-27 | view |
JXSL1900097 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-09-28 | | Bristol-Myers Squibb Company | In Review | 2019-09-27 | view |
JYSB1900287 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2019-10-18 | | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company | In Review | 2019-10-17 | view |
JYSB1900313 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2019-11-15 | | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company | In Review | 2019-11-14 | view |
JYSB1900340 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2019-12-11 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2020-01-21 | view |
JYSB1900339 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2019-12-11 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2020-01-21 | view |
JXSL1900150 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-12-21 | | Bristol-Myers Squibb Company | In Review | 2019-12-20 | view |
JXSS1900069 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-12-26 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2021-07-05 | view |
JXSS1900070 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-12-26 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2021-07-05 | view |
JXSL1900154 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2020-01-01 | | Bristol-Myers Squibb Company | In Review | 2019-12-31 | view |